Literature DB >> 18640217

Fragrance material review on alpha-bisabolol.

S P Bhatia1, D McGinty, C S Letizia, A M Api.   

Abstract

A toxicologic and dermatologic review of alpha-bisabolol when used as a fragrance ingredient is presented.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18640217     DOI： 10.1016/j.fct.2008.06.025

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN： 0278-6915            Impact factor:   6.023


  11 in total

1.  Leishmanicidal activity of α-bisabolol from Tunisian chamomile essential oil.

Authors:  Soumaya Hajaji; Ines Sifaoui; Atteneri López-Arencibia; María Reyes-Batlle; Ignacio A Jiménez; Isabel L Bazzocchi; Basilio Valladares; Hafidh Akkari; Jacob Lorenzo-Morales; José E Piñero
Journal:  Parasitol Res       Date:  2018-06-28       Impact factor: 2.289

2.  (-)-α-Bisabolol reduces orofacial nociceptive behavior in rodents.

Authors:  Luana Torres Melo; Mariana Araújo Braz Duailibe; Luciana Moura Pessoa; Flávio Nogueira da Costa; Antonio Eufrásio Vieira-Neto; Ana Paula de Vasconcellos Abdon; Adriana Rolim Campos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-11-29       Impact factor: 3.000

3.  Clinical efficacy of new α-bisabolol mouthwashes in postoperative complications of maxillofacial surgeries: a randomized, controlled, triple-blind clinical trial.

Authors:  Bruno Frota Amora-Silva; S C Ribeiro; C L Vieira; F R Mendes; A E Vieira-Neto; A P V Abdon; F N Costa; A R Campos
Journal:  Clin Oral Investig       Date:  2018-05-03       Impact factor: 3.573

Review 4.  The sesquiterpene α-bisabolol in the adipocyte-cancer desmoplastic crosstalk: does it have an action on epithelial-mesenchymal transition mechanisms?

Authors:  Salvatore Chirumbolo; Geir Bjørklund
Journal:  Int J Clin Oncol       Date:  2016-12-09       Impact factor: 3.402

5.  Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.

Authors:  V Corpas-López; G Merino-Espinosa; C Acedo-Sánchez; V Díaz-Sáez; M C Navarro-Moll; F Morillas-Márquez; J Martín-Sánchez
Journal:  Vet Res Commun       Date:  2018-02-16       Impact factor: 2.459

6.  Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells.

Authors:  Elisabetta Cavalieri; Antonella Rigo; Massimiliano Bonifacio; Alessandra Carcereri de Prati; Emanuele Guardalben; Christian Bergamini; Romana Fato; Giovanni Pizzolo; Hisanori Suzuki; Fabrizio Vinante
Journal:  J Transl Med       Date:  2011-04-21       Impact factor: 5.531

7.  Corneal antinociceptive effect of (-)-α-bisabolol.

Authors:  Gisele Façanha Diógenes Teixeira; Flávio Nogueira da Costa; Adriana Rolim Campos
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 8.  Health Benefits, Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of α-Bisabolol.

Authors:  Lujain Bader Eddin; Niraj Kumar Jha; Sameer N Goyal; Yogeeta O Agrawal; Sandeep B Subramanya; Salim M A Bastaki; Shreesh Ojha
Journal:  Nutrients       Date:  2022-03-25       Impact factor: 5.717

9.  Effect of α-Bisabolol and Its β-Cyclodextrin Complex as TetK and NorA Efflux Pump Inhibitors in Staphylococcus aureus Strains.

Authors:  Rafael Pereira da Cruz; Thiago Sampaio de Freitas; Maria do Socorro Costa; Antonia Thassya Lucas Dos Santos; Fábia Ferreira Campina; Raimundo Luiz Silva Pereira; José Weverton Almeida Bezerra; Lucindo José Quintans-Júnior; Adriano Antunes De Souza Araújo; José Pinto De Siqueira Júnior; Marcello Iriti; Elena Maria Varoni; Irwin Rose Alencar De Menezes; Henrique Douglas Melo Coutinho; Maria Flaviana Bezerra Morais-Braga
Journal:  Antibiotics (Basel)       Date:  2020-01-14

10.  In Vitro Scolicidal Activity of the Sesquiterpenes Isofuranodiene, α-Bisabolol and Farnesol on Echinococcus granulosus Protoscoleces.

Authors:  Mohammad Reza Youssefi; Ali Nikpay; Niloufar Hassanpour; Aida Mirzapour; Parisa Saleh Tabari; Roman Pavela; Filippo Maggi; Riccardo Petrelli
Journal:  Molecules       Date:  2020-08-07       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.